Furthermore, our human clinical trial showed the effectiveness of IGF1 hydrogel treatment in patients with idiopathic sudden sensorineural hearing loss that is refractory to glucocorticoid treatment [19]. This evidence concerns the gene IGF1 and sudden sensorineural hearing loss.